[go: up one dir, main page]

FI924405A - Lhrh-antagonister - Google Patents

Lhrh-antagonister Download PDF

Info

Publication number
FI924405A
FI924405A FI924405A FI924405A FI924405A FI 924405 A FI924405 A FI 924405A FI 924405 A FI924405 A FI 924405A FI 924405 A FI924405 A FI 924405A FI 924405 A FI924405 A FI 924405A
Authority
FI
Finland
Prior art keywords
lhrh antagonists
lhrh
antagonists
Prior art date
Application number
FI924405A
Other languages
English (en)
Other versions
FI924405A0 (fi
Inventor
Andrew V Schally
Tamas Janaky
Attila Juhasz
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of FI924405A0 publication Critical patent/FI924405A0/fi
Publication of FI924405A publication Critical patent/FI924405A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/32—Modification to prevent enzymatic degradation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI924405A 1991-01-30 1992-09-30 Lhrh-antagonister FI924405A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/647,786 US5171835A (en) 1988-10-21 1991-01-30 LHRH antagonists
PCT/US1992/000776 WO1992013883A1 (en) 1991-01-30 1992-01-29 Lhrh antagonists

Publications (2)

Publication Number Publication Date
FI924405A0 FI924405A0 (fi) 1992-09-30
FI924405A true FI924405A (fi) 1992-09-30

Family

ID=24598270

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924405A FI924405A (fi) 1991-01-30 1992-09-30 Lhrh-antagonister

Country Status (13)

Country Link
US (1) US5171835A (fi)
EP (1) EP0522152A1 (fi)
JP (1) JPH05505630A (fi)
CA (1) CA2079461A1 (fi)
FI (1) FI924405A (fi)
HU (1) HUT63635A (fi)
IE (1) IE920287A1 (fi)
LV (1) LV5806B4 (fi)
MX (1) MX9200342A (fi)
PT (1) PT100077B (fi)
TW (1) TW304198B (fi)
WO (1) WO1992013883A1 (fi)
ZA (1) ZA92600B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429186B1 (en) 1991-05-10 2002-08-06 Genentech, Inc. Ligand antagonists for treatment of breast cancer
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
EP0683792B1 (en) * 1992-12-18 2001-09-26 Abbott Laboratories Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
EP0708656B1 (en) * 1993-04-27 2002-07-31 United Biomedical, Inc. Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US6048863A (en) 1994-04-19 2000-04-11 Takeda Chemical Industries, Ltd. Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use
JP3138477B2 (ja) * 1994-07-22 2001-02-26 ザ メディカル カレッジ オブ ハンプトン ロード 長期治療処方のための持続性エストロゲン分泌の確立方法
US5843901A (en) 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
EP0876349B1 (en) * 1995-10-19 2002-09-11 Takeda Chemical Industries, Ltd. Quinoline derivatives as gnrh antagonists
CN1063446C (zh) * 1995-10-19 2001-03-21 武田药品工业株式会社 作为促性腺激素释放激素拮抗剂的噻吩并吡啶衍生物
US5828149A (en) * 1996-07-18 1998-10-27 Baker Hughes Incorported Lubricant inducer pump for electrical motor
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
FR2788527A1 (fr) 1999-01-15 2000-07-21 Bio Merieux Pseudopeptide, procede de synthese, reactif et applications
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
EP1274723A4 (en) * 1999-07-29 2003-10-01 Univ Johns Hopkins ACTIVATION OF PEPTIDE PRODRUGS BY hK2
EP1297850B1 (en) * 2000-07-05 2015-08-19 Takeda Pharmaceutical Company Limited Medicinal preparations for treating sex hormone-dependent diseases
US6583153B2 (en) 2000-12-12 2003-06-24 Ortho-Mcneil Pharmaceutical, Inc. 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
WO2003064429A1 (fr) 2002-01-30 2003-08-07 Takeda Chemical Industries, Ltd. Thienopyrimidines, procedes de fabrication et d'utilisation correspondants
EP1711159B1 (en) 2003-12-30 2013-03-20 Durect Corporation Solid implants containing a block copolymer for controlled release of a gnrh compound
ES2750651T3 (es) 2008-06-12 2020-03-26 Ipsen Bioinnovation Ltd Proteínas de fusión para uso en el tratamiento de acromegalia
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
PL3064498T3 (pl) 2013-10-30 2020-03-31 Shanghai Hengrui Pharmaceutical Co. Ltd. Pirazolopirymidon lub pochodne pirolotriazonu, sposób ich otrzymywania i ich zastosowania farmaceutyczne
US20220267347A1 (en) 2019-07-29 2022-08-25 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidinedione compounds and uses thereof
US20250000864A1 (en) 2021-11-01 2025-01-02 Shandong Luye Pharmaceutical Co., Ltd. Gonadotropin-releasing hormone antagonist, and preparation method therefor and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
EP0364819A3 (en) * 1988-10-21 1991-03-06 The Administrators of The Tulane Educational Fund Lhrh analogs
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
TW304198B (fi) 1997-05-01
FI924405A0 (fi) 1992-09-30
PT100077A (pt) 1993-04-30
LV5806B4 (lv) 1997-06-20
ZA92600B (en) 1992-10-28
LV5806A4 (lv) 1997-02-20
MX9200342A (es) 1992-08-01
PT100077B (pt) 1999-06-30
WO1992013883A1 (en) 1992-08-20
EP0522152A1 (en) 1993-01-13
IE920287A1 (en) 1992-07-29
CA2079461A1 (en) 1992-07-31
HUT63635A (en) 1993-09-28
US5171835A (en) 1992-12-15
HU9202778D0 (en) 1992-12-28
JPH05505630A (ja) 1993-08-19

Similar Documents

Publication Publication Date Title
FI924405A (fi) Lhrh-antagonister
DE69202186D1 (de) N-substituierte-4-Phenyl-Piperidin-Opioid Antagoniste.
DE69209470D1 (de) Verbinder
DE69218566D1 (de) Verbinder
NO932005D0 (no) Angiotensin-ii-antagonister
DE69233370D1 (de) Entwicklernachfüllcontainer
NO930543D0 (no) Doseringsform
DE69211387D1 (de) Verbinder
DE69123606D1 (de) Verbinder
DE69209612D1 (de) Verbinder
DE69204920D1 (de) Angiotensin-II-Antagoniste.
DK50392D0 (da) Gulvelement
ATA11391A (de) Beschlag
FI88467B (fi) Anordning foer skaerbraenning under vattnet
DE69232141D1 (de) Sender-Empfänger
FI911427A (fi) Skrivare
FI911686A (fi) Oikaisupuomi
ATA170491A (de) Mauerstein
NO921530L (no) Farmasoeytisk forbindelse
NO921529D0 (no) Farmasoeytisk forbindelse
EE04318B1 (et) Parendatud toimega LHRH antagonistid
FI930108A (fi) Imidazopyridin-paf-antagonister
BR9100209A (pt) Pulverizador astavel
FI935598A (fi) Lhrh-analoger
DE69206979D1 (de) Zerstäuber